0000000000807384

AUTHOR

Chloé Charlotte Schröder

0000-0002-4259-5319

showing 2 related works from this author

Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States

2020

Background: Breast cancer treatment has changed tremendously over the last decades. In addition, the use of mammography screening for early detection has increased strongly. To evaluate the impact of these developments, long-term trends in incidence, mortality, stage distribution and survival were investigated for Germany and the United States (US). Methods: Using population-based cancer registry data, long-term incidence and mortality trends (1975&ndash

trendsCancer ResearchUnited States ; Survival ; Trends ; Mortality ; Incidence ; Breast cancer ; GermanyBreast cancer mortalityPopulationsurvivallcsh:RC254-282Article03 medical and health sciencesbreast cancer0302 clinical medicineBreast cancerGermanyMedicine030212 general & internal medicineStage (cooking)Mortality trendseducationeducation.field_of_studyRelative survivalbusiness.industryIncidence (epidemiology)lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasemortalityUnited StatesCancer registryOncology030220 oncology & carcinogenesisincidencebusinessDemographyCancers
researchProduct

Disclosing progress in cancer survival with less delay

2019

Cancer registration plays a key role in monitoring the burden of cancer. However, cancer registry (CR) data are usually made available with substantial delay to ensure best possible completeness of case ascertainment. Here, we investigate empirically with routinely available data whether such a delay is mandatory for survival analyses or whether data can be used earlier to provide more up-to-date survival estimates. We compared distributions of prognostic factors and period relative survival estimates for three population-based CRs in Germany (Schleswig-Holstein (SH), Rhineland-Palatinate (RP), Saarland (SA)) computed on datasets extracted one (DY+1) to 5 years after the year of diagnosis (…

MaleOncologyCancer Researchmedicine.medical_specialtyTime FactorsPopulationCancer registrationEmpirical Research03 medical and health sciences0302 clinical medicineGermanyNeoplasmsInternal medicinemedicineHumansRegistrieseducationLung cancereducation.field_of_studyRelative survivalbusiness.industryCancer survivalmedicine.diseaseSurvival AnalysisCancer registryCase ascertainmentOncology030220 oncology & carcinogenesisFemalebusinessReference datasetInternational Journal of Cancer
researchProduct